Shisan Zukan
日本語

Frank TortiUS

President and Vant Chair, Roivant Sciences Ltd. (ROIV) (+1 more)

Net worth (est.)
$500.6M
#381 in the US
¥78.7B · US-listed shares
Dividends (a year)
$0
Latest filing
2026-06-30
Form 3/4/5 transaction date

Holdings

CompanyHeld bySharesPriceValueDividends
Roivant Sciences Ltd.
ROIV · President and Vant Chair
 Direct 13,536,202 $34.59 $468.2M —
Immunovant, Inc.
IMVT
 Direct 1,009,228 $32.11 $32.4M —
Estimated from SEC Form 3/4/5 holdings and prices from SEC Fails-to-Deliver and Form 13F data. Options and RSUs excluded. Source: U.S. Securities and Exchange Commission (EDGAR). SEC filings